Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.22 USD | +11.16% | +13.38% | +30.76% |
May. 03 | Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating | MT |
May. 02 | Transcript : LeMaitre Vascular, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Evolution of the average Target Price on LeMaitre Vascular, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering LeMaitre Vascular, Inc.
Barrington Research | |
Stifel Nicolaus | |
JMP Securities | |
Oppenheimer | |
Jefferies & Co. | |
Roth MKM | |
Roth Capital Partners | |
KeyBanc Capital Markets |
EPS Revisions
- Stock Market
- Equities
- LMAT Stock
- Consensus LeMaitre Vascular, Inc.